mounjaro glp-1 market impact Obesity Deep Dive: The Unparalleled Launch Success of and Zepbound GLP-1 Receptor Agonist Market Size,

"We know from our research on anabolic steroids in Australia that there's heavy metals, there's residual chemicals left over from the manufacturer and there's a lot of nasty stuff in there that's never really been researched thoroughly, and we expect peptides to be exactly the same," she said

BJU Int 2002;89:895-900

However, Epithalon remains investigational with no FDA approval, most research conducted in Russia with limited Western replication, long-term human safety data sparse, optimal dosing protocols still debated, and mechanisms not fully understood

What the Research Says About GLP-1 Therapy Clinical evidence behind GLP-1 medications is strong and still growing

Consult a licensed healthcare provider before starting any prescription therapy

For example, reported daily energy intake of GLP1-RA users is approximately 1750 to 2180 kcal per day